Neddylation and anti-tumor immunity

Oncotarget. 2021 Oct 12;12(21):2227-2230. doi: 10.18632/oncotarget.28019. eCollection 2021 Oct 12.ABSTRACTContrary to chemotherapy, novel targeted therapies are associated with diverse immunomodulatory effects. Nedd8 is a small ubiquitin-like modifier that is involved in regulation of protein degradation. Neddylation is a promising target in cancer. Pevonedistat, a small molecule inhibitor of the Nedd8-activating enzyme, demonstrates pre-clinical activity in multiple tumor types. Recent studies have revealed that neddylation is important in immunity. We and others have shown that interfering with neddylation causes downstream immunomodulatory effects potentially leading to enhanced anti-tumor immunity. Thus, Nedd8 is a promising target in immuno-oncology.PMID:34676055 | PMC:PMC8522835 | DOI:10.18632/oncotarget.28019
Source: Oncotarget - Category: Cancer & Oncology Authors: Source Type: research